Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

被引:43
作者
Amminger, G. P. [1 ,2 ]
Mechelli, A. [3 ]
Rice, S. [1 ,2 ]
Kim, S-W [4 ]
Klier, C. M. [5 ]
McNamara, R. K. [6 ]
Berk, M. [7 ]
McGorry, P. D. [1 ,2 ]
Schaefer, M. R. [1 ,2 ]
机构
[1] Univ Melbourne, Ctr Youth Mental Hlth, Natl Ctr Excellence Youth Mental Hlth, Orygen, Parkville, Vic 3052, Australia
[2] Melbourne Hlth, Parkville, Vic 3052, Australia
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England
[4] Chonnam Natl Univ, Sch Med, Dept Psychiat, Gwangju, South Korea
[5] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria
[6] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA
[7] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
POLYUNSATURATED FATTY-ACIDS; ETHYL-EICOSAPENTAENOIC ACID; ALPHA-LINOLENIC ACID; ERYTHROCYTE-MEMBRANES; INDICATED PREVENTION; OXIDATIVE STRESS; SCHIZOPHRENIA; DISEASE; CONVERSION; SYMPTOMS;
D O I
10.1038/tp.2014.134
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
Previous efforts in the prospective evaluation of individuals who experience attenuated psychotic symptoms have attempted to isolate mechanisms underlying the onset of full-threshold psychotic illness. In contrast, there has been little research investigating specific predictors of positive outcomes. In this study, we sought to determine biological and clinical factors associated with treatment response, here indexed by functional improvement in a pre-post examination of a 12-week randomized controlled intervention in individuals at ultra-high risk (UHR) for psychosis. Participants received either long-chain omega-3 (omega-3) polyunsaturated fatty acids (PUFAs) or placebo. To allow the determination of factors specifically relevant to each intervention, and to be able to contrast them, both treatment groups were investigated in parallel. Univariate linear regression analysis indicated that higher levels of erythrocyte membrane a-linolenic acid (ALA; the parent fatty acid of the omega-3 family) and more severe negative symptoms at baseline predicted subsequent functional improvement in the treatment group, whereas less severe positive symptoms and lower functioning at baseline were predictive in the placebo group. A multivariate machine learning analysis, known as Gaussian Process Classification (GPC), confirmed that baseline fatty acids predicted response to treatment in the omega-3 PUFA group with high levels of sensitivity, specificity and accuracy. In addition, GPC revealed that baseline fatty acids were predictive in the placebo group. In conclusion, our investigation indicates that UHR patients with higher levels of ALA may specifically benefit from omega-3 PUFA supplementation. In addition, multivariate machine learning analysis suggests that fatty acids could potentially be used to inform prognostic evaluations and treatment decisions at the level of the individual. Notably, multiple statistical analyses were conducted in a relatively small sample, limiting the conclusions that can be drawn from what we believe to be a first-of-its-kind study. Additional studies with larger samples are therefore needed to evaluate the generalizability of these findings.
引用
收藏
页码:e495 / e495
页数:7
相关论文
共 48 条
[1]
At Clinical High Risk for Psychosis: Outcome for Nonconverters [J].
Addington, Jean ;
Cornblatt, Barbara A. ;
Cadenhead, Kristin S. ;
Cannon, Tyrone D. ;
McGlashan, Thomas H. ;
Perkins, Diana O. ;
Seidman, Larry J. ;
Tsuang, Ming T. ;
Walker, Elaine F. ;
Woods, Scott W. ;
Heinssen, Robert .
AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (08) :800-805
[2]
Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals [J].
Amminger, G. P. ;
Leicester, S. ;
Yung, A. R. ;
Phillips, L. J. ;
Berger, G. E. ;
Francey, S. M. ;
Yuen, H. P. ;
McGorry, P. D. .
SCHIZOPHRENIA RESEARCH, 2006, 84 (01) :67-76
[3]
Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals [J].
Amminger, G. P. ;
Schaefer, M. R. ;
Klier, C. M. ;
Slavik, J-M ;
Holzer, I. ;
Holub, M. ;
Goldstone, S. ;
Whitford, T. J. ;
McGorry, P. D. ;
Berk, M. .
MOLECULAR PSYCHIATRY, 2012, 17 (12) :1150-1152
[4]
Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders [J].
Amminger, G. Paul ;
McGorry, Patrick D. .
NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) :309-310
[5]
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial [J].
Amminger, G. Paul ;
Schafer, Miriam R. ;
Papageorgiou, Konstantinos ;
Klier, Claudia M. ;
Cotton, Sue M. ;
Harrigan, Susan M. ;
Mackinnon, Andrew ;
McGorry, Patrick D. ;
Berger, Gregor E. .
ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (02) :146-154
[6]
Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression [J].
Anderson, George ;
Maes, Michael .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 :5-19
[7]
Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group [J].
Assies, J ;
Lieverse, R ;
Vreken, P ;
Wanders, RJA ;
Dingemans, PMJA ;
Linszen, DH .
BIOLOGICAL PSYCHIATRY, 2001, 49 (06) :510-522
[8]
Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study [J].
Berger, Gregor E. ;
Wood, Stephen J. ;
Wellard, R. Mark ;
Proffitt, Tina M. ;
McConchie, Mirabel ;
Amminger, G. Paul ;
Jackson, Graeme D. ;
Velakoulis, Dennis ;
Pantelis, Christos ;
McGorry, Patrick D. .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (10) :2467-2473
[9]
Bioactive lipids in schizophrenia [J].
Berger, Gregor E. ;
Smesny, Stefan ;
Amminger, G. Paul .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2006, 18 (02) :85-98
[10]
Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors [J].
Berk, M. ;
Kapczinski, F. ;
Andreazza, A. C. ;
Dean, O. M. ;
Giorlando, F. ;
Maes, M. ;
Yuecel, M. ;
Gama, C. S. ;
Dodd, S. ;
Dean, B. ;
Magalhaes, P. V. S. ;
Amminger, P. ;
McGorry, P. ;
Malhi, G. S. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2011, 35 (03) :804-817